Related Experiment Video
Updated: Aug 11, 2026

06:47
One-step Protocol for Evaluation of the Mode of Radiation-induced Clonogenic Cell Death by Fluorescence Microscopy
Published on: October 23, 2017
Persistent decrease in viability as a function of X irradiation of human bladder carcinoma cells in G1 or S phase
E A Leonhardt1, M Trinh, H B Forrester
1Radiation Oncology Research Laboratory, University of California San Francisco, 94103, USA.
Radiation Research
|April 3, 1998
Summary
Radiation damage in human bladder cancer cells persists longer when cells are irradiated in the G1 phase compared to the S phase, affecting long-term cell viability and recovery rates.
Area of Science:
- Cell Biology
- Radiation Oncology
- Cancer Research
Background:
- Cell cycle phase influences cellular response to DNA damage.
- Previous studies noted decreased viability after mutagenic treatment, but cell cycle phase dependence was underexplored.
Purpose of the Study:
- To investigate the impact of cell cycle phase (G1 vs. S) on human bladder carcinoma cell survival and recovery after radiation exposure.
- To determine if initial cell survival differences correlate with long-term progeny viability.
Main Methods:
- Synchronized human bladder carcinoma cells (EJ30-15) were irradiated in G1 or S phase.
- Cell survival was assessed via initial plating efficiency and clonogenic survival assays.
- Long-term recovery and viability were monitored over 33 days (up to 36 cell doublings).
Main Results:
- Initial clonogenic survival was similar for cells irradiated in G1 or S phase.
- Cells irradiated in S phase recovered plating efficiency faster (11 days) than those irradiated in G1 (20 days).
- G1-irradiated cells exhibited slower multiplication rates and increased multinucleated/giant cells post-irradiation.
Conclusions:
- While initial survival is unaffected, radiation-induced damage persists longer in progeny of G1-irradiated cells.
- Cell cycle phase is a critical determinant of long-term radiation damage persistence and cellular recovery.
- Targeting cell cycle for radiation therapy may optimize treatment outcomes by minimizing residual damage effects.

